Cardiovascular Toxicity Tumour Board

Dr Inbar Nardi Agmon is undertaking a two-year clinical fellowship at Toronto General Hospital, Ontario, CA. 

Following the completion of her subspecialty in cardiology and until July 2023, she served as the head of the cardio-oncology clinic at Beilinson Hospital, Rabin Medical Center, Israel. 

In addition to her clinical responsibilities and participation in clinical studies both in Israel and Toronto, Dr Nardi Agmon operates a basic-science laboratory in Israel, where she investigates the effects of immune checkpoint inhibitors on atherosclerosis. 

Dr Joshua Mitchell, MD, MSCI is an Associate Professor of Medicine, Director of the Cardio-Oncology Centre of Excellence and the Cardio-Oncology Fellowship at Washington University School of Medicine in St. Louis, US. He also serves as Co-Director of the Amyloid Centre of Excellence.

Before joining Washington University in 2015, Dr Mitchell dedicated 11 years to the Army, serving as a Field Artillery Officer and a physician with the 82nd Airborne Division and the 75th Ranger Regiment, achieving the rank of Major and earning two Bronze Star Medals.

In addition to his roles at Washington University, Dr Mitchell is a member of the editorial boards for JACC: Cardio-Oncology and the American Journal of Medicine. He chairs the IC-OS Patient Advocacy working group and is a member of the IC-OS Scientific Committee, having previously chaired the 2021 IC-OS expert consensus statement for cardiovascular disease screening in radiation survivors.

Dr Mitchell's clinical and research interests focus on understanding cardiovascular disease associated with cancer treatment and the diagnosis and management of cardiac amyloidosis. His research also explores the use of coronary artery calcium to enhance risk prediction and target preventive therapy.

Dr Clara Llamedo is a Clinical Fellow in Cardio-Oncology at Royal Brompton Hospital, London, UK.

Prior to joining the unit led by Dr Alexander Lyon, Dr Llamedo completed both her general cardiology and echocardiography training in Hospital Italiano de Buenos Aires in Argentina. During her training, she developed a keen interest in cardio-oncology and was invited to participate in clinical research in the field.
 

Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.

He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy. 

He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.

Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.

He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.